doi: 10.1017/s0266462300008011.
Technology assessment in a user perspective--experiences with drug technology
Affiliations
- PMID: 1601585
- DOI: 10.1017/s0266462300008011
Item in Clipboard
Technology assessment in a user perspective--experiences with drug technology
Int J Technol Assess Health Care.
1992 Winter.
Abstract
Drugs have a central place among medical technologies, and medical technology assessment can learn from the established regulation of drug technology. This article outlines how users' experiences are not part of the basis on which decisions are made today, although this knowledge is imperative for identifying the problems that are not uncovered or foreseen by today's drug assessments. Further, users' interests might not be part of assessments that are based on the controlled clinical trial. A framework for drug technology assessments based on a user perspective is suggested.
Similar articles
-
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].Theriaca. 2016;(43):9-61. Theriaca. 2016. PMID: 27491172 Danish.
-
The impact of an automated dose-dispensing scheme on user compliance, medication understanding, and medication stockpiles.Res Social Adm Pharm. 2007 Sep;3(3):265-84. doi: 10.1016/j.sapharm.2006.10.002. Res Social Adm Pharm. 2007. PMID: 17945158
-
Health technology assessment of medical devices: What is different? An overview of three European projects.Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):309-18. doi: 10.1016/j.zefq.2015.06.011. Epub 2015 Jul 26. Z Evid Fortbild Qual Gesundhwes. 2015. PMID: 26354131 Review.
-
Evaluation of medical equipment on the basis of users' experiences and hazard registration.Health Policy. 1989;11(1):61-72. doi: 10.1016/0168-8510(89)90056-0. Health Policy. 1989. PMID: 10292207
-
Time-trends in health technology assessments: an analysis of developments in composition of international health technology assessments from 1989 to 2002.Int J Technol Assess Health Care. 2005 Fall;21(4):492-8. doi: 10.1017/S0266462305050683. Int J Technol Assess Health Care. 2005. PMID: 16262973 Review.
Cited by
-
Side effects of antineoplastic and immunomodulating medications reported by European consumers.J Res Pharm Pract. 2013 Jan;2(1):44-9. doi: 10.4103/2279-042X.114091. J Res Pharm Pract. 2013. PMID: 24991604 Free PMC article.
-
Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.Drug Saf. 2010 Apr 1;33(4):327-39. doi: 10.2165/11319100-000000000-00000. Drug Saf. 2010. PMID: 20297864
-
The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies.Neuropsychiatr Dis Treat. 2011;7:729-44. doi: 10.2147/NDT.S26403. Epub 2011 Dec 16. Neuropsychiatr Dis Treat. 2011. PMID: 22247615 Free PMC article.
-
Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade.BMC Res Notes. 2010 Jun 23;3:176. doi: 10.1186/1756-0500-3-176. BMC Res Notes. 2010. PMID: 20573185 Free PMC article.
-
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.1007/BF03262002. Drug Saf. 2012. PMID: 23072620